Nasal Cannula Industry Overview
The global nasal cannula market size was valued at USD 6.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2021 to 2028. The factor attributing extensively to the growth of the market is the rise in the prevalence of respiratory diseases worldwide. Chronic respiratory diseases accounted for one of the leading causes of morbidity with about 40% of chronic respiratory disease cases increased from 1990 to 2017, majorly due to asthma and COPD.
The growth in the healthcare expenditure by most of the countries and government initiatives under the public healthcare system for affordable healthcare and awareness are expected to promote patient footfall. In addition, the lifestyle shift, rise in smoker’s percentage, climatic conditions, and the increasing air pollution contribute majorly towards the rise in respiratory diseases further resulting in the market growth of nasal cannula.
Gather more insights about the market drivers, restraints and growth of the Global Nasal Cannula Market
Moreover, the current Covid-19 pandemic has further propelled the demand for nasal cannulas worldwide, the high-flow nasal cannula oxygenation therapy was recommended as a standard therapy across the U.S. by the Center for Disease Control and Prevention and the single-use nasal cannula witnessed a surge in demand.
The rising demand and adoption of the nasal cannula are addressed by the growing number of manufacturers and suppliers worldwide. The key players of the market with their wide distribution network have enabled the availability of technologically advanced products worldwide. The development in the nasal cannula as a silicone material, extra soft, latex-free, curved, and flared cannulas, to improve the comfort and flexibility, and the growing adoption of high flow nasal cannula in chronic respiratory disease treatment has expanded the scope and usage of the nasal cannula in patients of all ages. Furthermore, the growing e-commerce channel has enabled the availability of the products worldwide, including home care setting further fueling the adoption of the nasal cannula and market growth.
Browse through Grand View Research's Healthcare Industry Related Reports
Ambulatory Services Market - The global ambulatory services market size was valued at USD 2.72 trillion in 2018 and is projected to expand at a CAGR of 6.1% over the forecast period.
Long Term Care Devices Market - The global long term care devices market size was valued at USD 141.4 billion in 2018 and is expected to grow at a CAGR of 8.5% over the forecast period.
Nasal Cannula Industry Segmentation
Grand View Research has segmented the global nasal cannula market based on type, material, end-use, and region:
Nasal Cannula Type Outlook (Revenue, USD Million, 2016 - 2028)
- Low Flow
- High Flow
Nasal Cannula Material (Revenue, USD Million, 2016 - 2028)
- Plastic
- Silicone
Nasal Cannula End-use Outlook (Revenue, USD Million, 2016 - 2028)
- Hospitals
- Ambulatory Healthcare Services
- Long Term Care Centers
- Others
Nasal Cannula Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- MEA (Middle East & Africa)
Key Companies profiled:
Some prominent players in the global Nasal Cannula Industry include
- Allied Healthcare Products, Inc.
- Teleflex Incorporated
- Flexicare Medical Ltd.
- Vapotherm Inc.
- ResMed Inc.
- Fairmont Medical
- Fisher & Paykel Healthcare Limited
- Well Lead Medical Co. Ltd.
- Salter Labs
Order a free sample PDF of the Nasal Cannula Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment